Stockscreener 앱 받기
0.3963
0.18%
-0.0007
시간 외 거래:
.38
-0.0163
-4.11%
전일 마감가:
$0.397
열려 있는:
$0.4085
하루 거래량:
494.52K
Relative Volume:
0.06
시가총액:
$58.08M
수익:
$49.09M
순이익/손실:
$-52.15M
주가수익비율:
-0.6097
EPS:
-0.65
순현금흐름:
$-45.93M
1주 성능:
-1.05%
1개월 성능:
+29.43%
6개월 성능:
-59.77%
1년 성능:
-77.16%
1일 변동 폭
$0.3801
$0.4085
1주일 범위
$0.3702
$0.4329
52주 변동 폭
$0.1718
$2.04
바이오데식스 Stock (BDSX) Company Profile
명칭
Biodesix Inc
전화
303-417-0500
주소
919 WEST DILLON ROAD, LOUISVILLE
BDSX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BDSX
Biodesix Inc
|
0.3963 | 58.21M | 49.09M | -52.15M | -45.93M | -0.65 |
|
TMO
Thermo Fisher Scientific Inc
|
489.01 | 183.16B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
210.93 | 150.53B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
650.84 | 52.32B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
119.20 | 33.77B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
191.09 | 32.20B | 15.50B | 1.33B | 2.16B | 7.34 |
바이오데식스 Stock (BDSX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-14 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2024-09-16 | 개시 | Scotiabank | Sector Outperform |
| 2024-07-26 | 개시 | Craig Hallum | Buy |
| 2024-05-13 | 개시 | TD Cowen | Buy |
| 2024-05-03 | 개시 | Lake Street | Buy |
| 2021-11-17 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-11-23 | 개시 | BTIG Research | Buy |
| 2020-11-23 | 개시 | Canaccord Genuity | Buy |
| 2020-11-23 | 개시 | Morgan Stanley | Overweight |
| 2020-11-23 | 개시 | William Blair | Outperform |
모두보기
바이오데식스 주식(BDSX)의 최신 뉴스
What MACD and RSI say about Biodesix Inc.Portfolio Risk Summary & Weekly Breakout Watchlists - Newser
Biodesix (NASDAQ:BDSX) Releases Earnings Results - MarketBeat
Combining machine learning predictions for Biodesix Inc.2025 Technical Patterns & Risk Managed Investment Signals - Newser
Price momentum metrics for Biodesix Inc. explainedJuly 2025 Decliners & Smart Money Movement Alerts - Newser
Combining price and volume data for Biodesix Inc.Quarterly Profit Review & Community Verified Watchlist Alerts - Newser
Is This the Dip to Buy in Biodesix Inc.Weekly Trade Review & Reliable Breakout Stock Forecasts - beatles.ru
AI Indicators Detect Buy Opportunity in Biodesix Inc.CEO Change & Fast Entry and Exit Trade Plans - kangso.co.kr
Can Biodesix Inc. Outperform Peers After Recent PullbackExit Point & Proven Capital Preservation Methods - thegnnews.com
Blair William & Co. IL Has $78,000 Stake in Biodesix, Inc. (NASDAQ:BDSX) - Defense World
Is a relief rally coming for Biodesix Inc. holders2025 Performance Recap & AI Powered Buy and Sell Recommendations - Newser
Biodesix, Inc. Reports Strong Q2 2025 Growth - MSN
Will Biodesix Inc. bounce back from current supportFed Meeting & Risk Managed Investment Strategies - Newser
Earnings visualization tools for Biodesix Inc.2025 Market Sentiment & Free AI Powered Buy and Sell Recommendations - Newser
Biodesix at Canaccord Conference: Strategic Expansion in Diagnostics By Investing.com - Investing.com Canada
Is Biodesix Inc. a strong growth stockUndervalued High Return Candidates - kangso.co.kr
Investors Still Aren't Entirely Convinced By Biodesix, Inc.'s (NASDAQ:BDSX) Revenues Despite 26% Price Jump - 富途牛牛
Biodesix, Inc. (NASDAQ:BDSX) Q2 2025 Earnings Call Transcript - Insider Monkey
What makes Biodesix Inc. stock price move sharplyReversal Pattern Insights with Entry Tips - Newser
Biodesix, Inc. (NASDAQ:BDSX) Just Reported Earnings, And Analysts Cut Their Target Price - 富途牛牛
Should I add Biodesix Inc. stock to my portfolioMulti-Year Breakout Candidates - thegnnews.com
Earnings Release: Here's Why Analysts Cut Their Biodesix, Inc. (NASDAQ:BDSX) Price Target To US$1.80 - Yahoo Finance
Biodesix 2025 Q2 Earnings Revenue Grows 11.7% Amid Expanding Losses - AInvest
Biodesix reports strong Q2 revenue growth - BizWest
Biodesix, Inc. (BDSX) Reports Q2 Loss, Tops Revenue Estimates - MSN
Biodesix, Inc. shares fall 9.84% intraday despite Q2 revenue beating estimates. - AInvest
Transcript : Biodesix, Inc., Q2 2025 Earnings Call, Aug 07, 2025 - MarketScreener
Biodesix Plunges 11.63% on Q2 Loss, Revenue Surprise - AInvest
Biodesix Reports Strong Q2 2025 Revenue Growth - TipRanks
Biodesix Maintains Hold Rating Amid Revenue Growth and Cash Flow Challenges - AInvest
Biodesix Inc (BDSX) Q2 2025 Earnings Call Highlights: Revenue Growth and Strategic Expansion ... By GuruFocus - Investing.com Canada
Biodesix Inc (BDSX) Q2 2025 Earnings Call Highlights: Revenue Gr - GuruFocus
Biodesix Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Biodesix Outpaces Expectations With Lung Test Growth And Upbeat Outlook - Finimize
Diagnostic firm Biodesix Q2 revenue beats estimates - MarketScreener
Biodesix earnings missed, revenue topped estimates By Investing.com - Investing.com South Africa
Biodesix earnings missed, revenue topped estimates - Investing.com
Biodesix Announces Second Quarter 2025 Results and Highlights - The Manila Times
Biodesix Soars 14.1% on Conference Presentation - AInvest
Biodesix Stock Soars 12.82% on Strong Q1 Earnings - AInvest
Biodesix Inc (BDSX) Stock: A Year of Stock Market Ups and Downs - investchronicle.com
Biodesix shares rise 4.26% premarket after announcing CEO and CFO to present at Canaccord Genuity 45th Annual Growth Conference. - AInvest
Biodesix Inc expected to post a loss of 7 cents a shareEarnings Preview - TradingView
Biodesix shares rise 1.30% premarket after announcing CEO and CFO to present at Canaccord Genuity 45th Annual Growth Conference. - AInvest
Biodesix's Strategic Momentum in Diagnostic Innovation and Market Expansion: A Compelling Buy in the High-Growth Diagnostics Sector - AInvest
Biodesix Leadership Team Set for Exclusive Fireside Chat at Major Growth Conference - Stock Titan
Biodesix to Present at the Canaccord Genuity 45th Annual Growth Conference - GlobeNewswire
Craig-Hallum Maintains Biodesix(BDSX.US) With Buy Rating - 富途牛牛
Why is Biodesix Inc. stock attracting strong analyst attentionMaximize portfolio value with timely trades - Jammu Links News
What institutional investors are buying Biodesix Inc. stockAchieve rapid portfolio appreciation today - Jammu Links News
Is Biodesix Inc. stock overvalued or undervaluedCapitalize on emerging market opportunities - Jammu Links News
Biodesix Inc. Stock Analysis and ForecastFree High-Return Strategy Alerts - Jammu Links News
바이오데식스 (BDSX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.67%
0.75%
자본화:
|
볼륨(24시간):